267 filings
Page 12 of 14
8-K
a8fga0y3 xqnx8d
18 Mar 16
Heat Biologics Announces Public Offering of Common Stock and Warrants
12:00am
8-K
coqt2wd7ri52ol8ayi
16 Mar 16
Regulation FD Disclosure
12:00am
8-K
58ruyx wavczv8km
3 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
ylbm9p 0x
25 Feb 16
Heat Biologics Provides Update on its HS-410 Phase 2 Monotherapy Bladder Cancer Trial Arm
12:00am
8-K
1p9dsf5jz3haosqmxp
23 Feb 16
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
tfwnmcx
18 Feb 16
Heat Biologics Reports Fiscal Year 2015 Financial Results
12:00am
8-K
pny39h4sxlh
27 Jan 16
Regulation FD Disclosure
12:00am
8-K
zu012rv
15 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K
ubogfbevfv
8 Dec 15
Termination of a Material Definitive Agreement
12:00am
8-K
4qdvue
1 Dec 15
Heat Biologics Appoints Timothy Creech as Chief Financial Officer
12:00am
8-K
g19v235w
9 Nov 15
Regulation FD Disclosure
12:00am
8-K
0a1e6jxb0
30 Oct 15
Heat Biologics Releases Third Quarter 2015 Financial Results
12:00am
8-K
hn72aax9 1i0e
1 Sep 15
Heat Biologics Announces Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC
12:00am
8-K
zqep4u5e7xekn4
13 Aug 15
Results of Operations and Financial Condition
12:00am
8-K
vhty4d2xtmwe
27 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
us56arq2r1da73 vm0
24 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
iqhqdzlx866
15 Jun 15
Heat Biologics Announces Development of ComPACT, a Next Generation Combination Immunotherapy Platform
12:00am
8-K
0mgvuh sn
29 May 15
Regulation FD Disclosure
12:00am
8-K
4217ukw2
14 May 15
Results of Operations and Financial Condition
12:00am
8-K
qsgw2 o06r
27 Mar 15
Results of Operations and Financial Condition
12:00am